Adma Biologics (ADMA)

$8.97 -0.11 (-1.21%)
Market Cap 2.10B
Revenue (ttm) 510.17M
Net Income (ttm) 146.93M
EPS (ttm) N/A
PE Ratio 13.24
Forward PE 11.31
Profit Margin 28.80%
Debt to Equity Ratio 0.50
Volume 2,874,200
Avg Vol 4,745,634
Day's Range N/A - N/A
Shares Out 231.77M
Stochastic %K 65%
Beta 0.73
Analysts Sell
Price Target $16.20

Company Profile

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the tre...

Industry: Biotechnology
Sector: Healthcare
Phone: 201 478 5552
Fax: 201 478 5553
Address:
465 State Route 17, Ramsey, United States
LongOrShortToMakeMoney
LongOrShortToMakeMoney Jul. 13 at 4:26 PM
$ADMA where is 6.x?
1 · Reply
GoldmanSlaps
GoldmanSlaps Jul. 9 at 9:20 PM
$ADMA
0 · Reply
StockBraker
StockBraker Jul. 9 at 2:52 PM
$ADMA
0 · Reply
StockBraker
StockBraker Jul. 9 at 12:13 PM
$ADMA Volume is only 890 at the moment PM. Not going to get too excited.
1 · Reply
LHBhandy
LHBhandy Jul. 8 at 3:50 PM
$ADMA holding up pretty good in this SS of a day!!!!
0 · Reply
DoctorLeoMarvin
DoctorLeoMarvin Jul. 7 at 4:50 PM
$ADMA ok, now this looks promising
0 · Reply
Princeredyr
Princeredyr Jul. 7 at 12:53 PM
$ADMA 10s on deck .
0 · Reply
GoldmanSlaps
GoldmanSlaps Jul. 6 at 9:50 PM
$ADMA there was a biotech buyout today in after hours good news for sector it was at 100% premium 👌🏼
1 · Reply
BullMaven
BullMaven Jul. 6 at 8:00 PM
$ADMA solid close. huge buy order at close
1 · Reply
BullMaven
BullMaven Jul. 6 at 3:44 PM
$ADMA SMA200 will be crossed by the end of July
0 · Reply
Latest News on ADMA
$ADMA Fraud Notification: ADMA Biologics Sued for Securities Fraud After Channel Stuffing Claims Spark a 29% Stock Drop – Investors Notified to Contact BFA Law by August 10

Jul 6, 2026, 6:48 AM EDT - 7 days ago

$ADMA Fraud Notification: ADMA Biologics Sued for Securities Fraud After Channel Stuffing Claims Spark a 29% Stock Drop – Investors Notified to Contact BFA Law by August 10

ADMA INVESTOR REMINDER: ADMA Biologics, Inc. Investors Have Until August 10, 2026 To Seek Lead Plaintiff Role

Jul 2, 2026, 7:00 PM EDT - 11 days ago

ADMA INVESTOR REMINDER: ADMA Biologics, Inc. Investors Have Until August 10, 2026 To Seek Lead Plaintiff Role

ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.

Jun 30, 2026, 9:19 AM EDT - 13 days ago

ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.

ADMA BIOLOGICS, INC. (ADMA) INVESTOR ALERT Investors With Large Losses in ADMA Biologics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Jun 24, 2026, 9:24 AM EDT - 19 days ago

ADMA BIOLOGICS, INC. (ADMA) INVESTOR ALERT Investors With Large Losses in ADMA Biologics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Grabar Law Office Investigates ADMA Biologics, Inc. (ADMA) on Behalf of Long-Term Shareholders

Jun 23, 2026, 7:55 AM EDT - 20 days ago

Grabar Law Office Investigates ADMA Biologics, Inc. (ADMA) on Behalf of Long-Term Shareholders

20 growth stocks priced as value stocks

Jun 15, 2026, 10:53 AM EDT - 4 weeks ago

20 growth stocks priced as value stocks

AMG ANIP ARR BILL CG DAN EFC

$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop – Investors Notified to Contact BFA Law

Jun 11, 2026, 1:33 PM EDT - 4 weeks ago

$ADMA Breaking News: ADMA Biologics Sued for Securities Fraud after Channel Stuffing Claims Lead to 16% Stock Drop – Investors Notified to Contact BFA Law

Adma Biologics resumed with an Outperform at Raymond James

2026-06-10T11:40:39.000Z - 4 weeks ago

Adma Biologics resumed with an Outperform at Raymond James

ADMA Biologics Investigation: ADMA Biologics (ADMA) Investigated for Alleged Channel Stuffing – Contact BFA Law if You Suffered Losses

Jun 10, 2026, 6:41 AM EDT - 4 weeks ago

ADMA Biologics Investigation: ADMA Biologics (ADMA) Investigated for Alleged Channel Stuffing – Contact BFA Law if You Suffered Losses

ADMA Legal Claims: ADMA Biologics may have Misrepresented its Revenue Sources to Investors – Contact BFA Law about its Pending Securities Fraud Investigation

Jun 3, 2026, 6:07 AM EDT - 5 weeks ago

ADMA Legal Claims: ADMA Biologics may have Misrepresented its Revenue Sources to Investors – Contact BFA Law about its Pending Securities Fraud Investigation

ADMA Biologics Transcript: AGM 2026

Jun 2, 2026, 10:00 AM EDT - 5 weeks ago

ADMA Biologics Transcript: AGM 2026

$ADMA Securities News: ADMA Biologics Investigated for Securities Fraud Over Channel Stuffing Allegations – Investors with Losses Notified to Contact BFA Law

May 29, 2026, 6:33 AM EDT - 6 weeks ago

$ADMA Securities News: ADMA Biologics Investigated for Securities Fraud Over Channel Stuffing Allegations – Investors with Losses Notified to Contact BFA Law

$ADMA Shareholder Announcement: ADMA Biologics may have Misled Investors about its Revenue – Contact BFA Law about its Pending Investigation

May 25, 2026, 7:18 AM EDT - 7 weeks ago

$ADMA Shareholder Announcement: ADMA Biologics may have Misled Investors about its Revenue – Contact BFA Law about its Pending Investigation

ADMA Inquiry News: ADMA Biologics Investors are Notified of BFA Law's Ongoing Investigation into the Company's Potential Misstatements – Contact the Firm if You Lost Money

May 22, 2026, 6:43 AM EDT - 7 weeks ago

ADMA Inquiry News: ADMA Biologics Investors are Notified of BFA Law's Ongoing Investigation into the Company's Potential Misstatements – Contact the Firm if You Lost Money

ADMA Securities Investigation: ADMA Biologics 29% Stock Drop Triggers Securities Fraud Investigation Over Channel Stuffing Claims – Investors Urged to Contact BFA Law

May 20, 2026, 6:20 AM EDT - 7 weeks ago

ADMA Securities Investigation: ADMA Biologics 29% Stock Drop Triggers Securities Fraud Investigation Over Channel Stuffing Claims – Investors Urged to Contact BFA Law

ADMA Fraud Notice: ADMA Biologics is being Investigated for Securities Fraud after 29% Stock Drop -- Investors Reminded to Contact BFA Law

May 18, 2026, 6:07 AM EDT - 2 months ago

ADMA Fraud Notice: ADMA Biologics is being Investigated for Securities Fraud after 29% Stock Drop -- Investors Reminded to Contact BFA Law

ADMA Shareholder News: ADMA Biologics Investigated for Securities Fraud Over Alleged Misrepresentations about Channel Stuffing – Investors Notified to Contact BFA Law

May 15, 2026, 6:33 AM EDT - 2 months ago

ADMA Shareholder News: ADMA Biologics Investigated for Securities Fraud Over Alleged Misrepresentations about Channel Stuffing – Investors Notified to Contact BFA Law

$ADMA Investigation Reminder: ADMA Biologics Investigation on behalf of Investors is Ongoing – Contact BFA Law if You Lost Money

May 11, 2026, 6:15 AM EDT - 2 months ago

$ADMA Investigation Reminder: ADMA Biologics Investigation on behalf of Investors is Ongoing – Contact BFA Law if You Lost Money

$ADMA Investor News: ADMA Biologics Stock Drops 29% Amid Channel Stuffing Claims Triggering Securities Fraud Investigation – Contact BFA Law if You Suffered Losses

May 8, 2026, 6:07 AM EDT - 2 months ago

$ADMA Investor News: ADMA Biologics Stock Drops 29% Amid Channel Stuffing Claims Triggering Securities Fraud Investigation – Contact BFA Law if You Suffered Losses

Adma Biologics price target lowered to $20 from $24 at Mizuho

2026-05-07T16:02:55.000Z - 2 months ago

Adma Biologics price target lowered to $20 from $24 at Mizuho

ADMA Biologics Stock Alert (ADMA) - Kehoe Law Firm, P.C. Investigating Potential Securities Claims on Behalf of ADMA Biologics Investors

May 7, 2026, 9:16 AM EDT - 2 months ago

ADMA Biologics Stock Alert (ADMA) - Kehoe Law Firm, P.C. Investigating Potential Securities Claims on Behalf of ADMA Biologics Investors

Adma Biologics price target lowered to $18 from $21 at Canaccord

2026-05-07T10:48:12.000Z - 2 months ago

Adma Biologics price target lowered to $18 from $21 at Canaccord

Adma Biologics reports Q1 EPS 19c, consensus 20c

2026-05-07T00:37:49.000Z - 2 months ago

Adma Biologics reports Q1 EPS 19c, consensus 20c

Adma Biologics sees FY26 revenue $530M-$560M, consensus $629.1M

2026-05-07T00:36:02.000Z - 2 months ago

Adma Biologics sees FY26 revenue $530M-$560M, consensus $629.1M

ADMA Biologics Earnings Call Transcript: Q1 2026

May 6, 2026, 4:30 PM EDT - 2 months ago

ADMA Biologics Earnings Call Transcript: Q1 2026

ADMA Biologics Earnings release: Q1 2026

May 6, 2026, 4:30 PM EDT - 2 months ago

ADMA Biologics Earnings release: Q1 2026

ADMA Biologics Quarterly report: Q1 2026

May 6, 2026, 4:30 PM EDT - 2 months ago

ADMA Biologics Quarterly report: Q1 2026

ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business Update

May 6, 2026, 4:05 PM EDT - 2 months ago

ADMA Biologics Reports First Quarter 2026 Financial Results and Provides Business Update

$ADMA Shareholder News: ADMA Biologics 29% Stock Drop Leads to Securities Fraud Investigation – BFA Law Encourages Investors with Losses to Act

May 6, 2026, 6:41 AM EDT - 2 months ago

$ADMA Shareholder News: ADMA Biologics 29% Stock Drop Leads to Securities Fraud Investigation – BFA Law Encourages Investors with Losses to Act

Adma Biologics announces FDA approval for Asceniv sBLA

2026-05-04T11:31:54.000Z - 2 months ago

Adma Biologics announces FDA approval for Asceniv sBLA

ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older

May 4, 2026, 7:00 AM EDT - 2 months ago

ADMA Biologics Announces FDA Approval to Expand the Label for ASCENIV™ to Include Pediatric Immune Compromised Patients Two Years of Age and Older

Investor Notice: ADMA Biologics (NASDAQ:ADMA) may have Committed Securities Fraud after Channel Stuffing Claims Disclosed – Contact BFA Law about the Pending Investigation

May 1, 2026, 6:16 AM EDT - 2 months ago

Investor Notice: ADMA Biologics (NASDAQ:ADMA) may have Committed Securities Fraud after Channel Stuffing Claims Disclosed – Contact BFA Law about the Pending Investigation

ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026

Apr 29, 2026, 7:00 AM EDT - 2 months ago

ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026

$ADMA Fraud: ADMA Biologics Channel Stuffing Claims Trigger Securities Investigation – Investors Alerted to Contact BFA Law

Apr 29, 2026, 6:41 AM EDT - 2 months ago

$ADMA Fraud: ADMA Biologics Channel Stuffing Claims Trigger Securities Investigation – Investors Alerted to Contact BFA Law

ADMA Stock: ADMA Biologics Securities Fraud Investigation is Ongoing – Investors with Losses Urged to Contact BFA Law

Apr 27, 2026, 6:38 AM EDT - 2 months ago

ADMA Stock: ADMA Biologics Securities Fraud Investigation is Ongoing – Investors with Losses Urged to Contact BFA Law

$ADMA Investigation: BFA Law Notifies ADMA Biologics Investors that Lost Money after 29% Stock Drop of Ongoing Securities Fraud Investigation

Apr 22, 2026, 6:05 AM EDT - 2 months ago

$ADMA Investigation: BFA Law Notifies ADMA Biologics Investors that Lost Money after 29% Stock Drop of Ongoing Securities Fraud Investigation

Adma Biologics initiated with a Buy at Canaccord

2026-04-21T09:25:41.000Z - 2 months ago

Adma Biologics initiated with a Buy at Canaccord

Adma Biologics initiated with a Buy at Canaccord

2026-04-20T20:45:12.000Z - 3 months ago

Adma Biologics initiated with a Buy at Canaccord

ADMA Securities News: ADMA Biologics Hit with Securities Fraud Investigation after Channel Stuffing Claims Trigger 29% Stock Drop – Investors Urged to Contact BFA Law

Apr 20, 2026, 6:33 AM EDT - 3 months ago

ADMA Securities News: ADMA Biologics Hit with Securities Fraud Investigation after Channel Stuffing Claims Trigger 29% Stock Drop – Investors Urged to Contact BFA Law

Stock Notification: ADMA Biologics (NASDAQ:ADMA) Securities Fraud Investigation Over Channel Stuffing Claims is Ongoing – Contact BFA Law if You Lost Money

Apr 17, 2026, 6:46 AM EDT - 3 months ago

Stock Notification: ADMA Biologics (NASDAQ:ADMA) Securities Fraud Investigation Over Channel Stuffing Claims is Ongoing – Contact BFA Law if You Lost Money

ADMA Biologics Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 3 months ago

ADMA Biologics Proxy statement: Proxy filing

ADMA Biologics Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 3 months ago

ADMA Biologics Proxy statement: Proxy filing

$ADMA Legal News: ADMA Biologics Investors may have been Affected by Fraud after Channel Stuffing Claims Disclosed – Contact BFA Law if You Lost Money

Apr 15, 2026, 6:07 AM EDT - 3 months ago

$ADMA Legal News: ADMA Biologics Investors may have been Affected by Fraud after Channel Stuffing Claims Disclosed – Contact BFA Law if You Lost Money

Adma Biologics price target lowered to $24 from $30 at Mizuho

2026-04-13T14:43:12.000Z - 3 months ago

Adma Biologics price target lowered to $24 from $30 at Mizuho

$ADMA Investigation Reminder: ADMA Biologics Investors are Reminded to Contact BFA Law after Company Investigated for Securities Fraud Over Channel Stuffing Claims

Apr 13, 2026, 6:35 AM EDT - 3 months ago

$ADMA Investigation Reminder: ADMA Biologics Investors are Reminded to Contact BFA Law after Company Investigated for Securities Fraud Over Channel Stuffing Claims

ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop — BFA Law

Apr 9, 2026, 6:07 AM EDT - 3 months ago

ADMA Fraud Notice: ADMA Biologics Investors are Notified the Company is being Investigated for Securities Fraud after 29% Stock Drop — BFA Law

ADMA Investor Announcement: ADMA Biologics Investigated After Channel Stuffing Claims Cause 29% Stock Drop – Investors with Losses Notified to Contact BFA Law

Apr 8, 2026, 6:16 AM EDT - 3 months ago

ADMA Investor Announcement: ADMA Biologics Investigated After Channel Stuffing Claims Cause 29% Stock Drop – Investors with Losses Notified to Contact BFA Law

Adma Biologics responds to short seller report by Culper Research

2026-03-27T11:42:03.000Z - 3 months ago

Adma Biologics responds to short seller report by Culper Research

Adma Biologics falls -15.9%

2026-03-26T16:06:09.000Z - 3 months ago

Adma Biologics falls -15.9%

Adma Biologics falls -19.9%

2026-03-26T14:07:02.000Z - 3 months ago

Adma Biologics falls -19.9%

Cantor downgrades Adma Biologics on lack of clarity post short report

2026-03-26T08:50:09.000Z - 3 months ago

Cantor downgrades Adma Biologics on lack of clarity post short report

Adma Biologics says Culper report contains ‘inaccurate statements’

2026-03-25T23:25:28.000Z - 3 months ago

Adma Biologics says Culper report contains ‘inaccurate statements’

Adma Biologics downgraded to Neutral from Overweight at Cantor Fitzgerald

2026-03-25T23:25:22.000Z - 3 months ago

Adma Biologics downgraded to Neutral from Overweight at Cantor Fitzgerald

Adma Biologics falls -12.6%

2026-03-25T16:06:37.000Z - 3 months ago

Adma Biologics falls -12.6%

LongOrShortToMakeMoney
LongOrShortToMakeMoney Jul. 13 at 4:26 PM
$ADMA where is 6.x?
1 · Reply
GoldmanSlaps
GoldmanSlaps Jul. 9 at 9:20 PM
$ADMA
0 · Reply
StockBraker
StockBraker Jul. 9 at 2:52 PM
$ADMA
0 · Reply
StockBraker
StockBraker Jul. 9 at 12:13 PM
$ADMA Volume is only 890 at the moment PM. Not going to get too excited.
1 · Reply
LHBhandy
LHBhandy Jul. 8 at 3:50 PM
$ADMA holding up pretty good in this SS of a day!!!!
0 · Reply
DoctorLeoMarvin
DoctorLeoMarvin Jul. 7 at 4:50 PM
$ADMA ok, now this looks promising
0 · Reply
Princeredyr
Princeredyr Jul. 7 at 12:53 PM
$ADMA 10s on deck .
0 · Reply
GoldmanSlaps
GoldmanSlaps Jul. 6 at 9:50 PM
$ADMA there was a biotech buyout today in after hours good news for sector it was at 100% premium 👌🏼
1 · Reply
BullMaven
BullMaven Jul. 6 at 8:00 PM
$ADMA solid close. huge buy order at close
1 · Reply
BullMaven
BullMaven Jul. 6 at 3:44 PM
$ADMA SMA200 will be crossed by the end of July
0 · Reply
Merlintrader
Merlintrader Jul. 6 at 1:17 PM
$ADMA ADMA Biologics (Nasdaq: $ADMA): The Full Updated Deep Dive Into ASCENIV, Q1 2026, IVIG Market Pressure, Margin Expansion and the Revenue-Quality Test Updated july 6 https://www.merlintrader.com/adma-biologics-stock-hub/
0 · Reply
LongOrShortToMakeMoney
LongOrShortToMakeMoney Jul. 4 at 9:22 PM
$ADMA over 9 is unacceptable
3 · Reply
GoldmanSlaps
GoldmanSlaps Jul. 4 at 8:50 PM
$ADMA happy 4th to my longs 🍻
1 · Reply
LHBhandy
LHBhandy Jul. 3 at 11:08 AM
$ADMA you got a 6, it’s just upside down!!!!!
0 · Reply
LongOrShortToMakeMoney
LongOrShortToMakeMoney Jul. 3 at 5:30 AM
$ADMA fake green. Happy July 4 everyone
1 · Reply
GoldmanSlaps
GoldmanSlaps Jul. 2 at 9:02 PM
$ADMA
0 · Reply
steveADMAbull
steveADMAbull Jul. 2 at 3:02 PM
$ADMA higher highs and higher lows this week... lets see a breakout above 9$ !!!!
0 · Reply
LongOrShortToMakeMoney
LongOrShortToMakeMoney Jul. 2 at 1:08 PM
$ADMA wrong color
1 · Reply
GoldmanSlaps
GoldmanSlaps Jul. 2 at 4:22 AM
$ADMA we used to have big cakes now we get this
1 · Reply
k3vl4r
k3vl4r Jul. 1 at 10:45 PM
I’ve been watching $ADMA for a while, and the recent lawsuit and price jags could be a trap or a trampoline. The roe is up, but don’t let the headwinds lull you into a false sense of security. Check out this forecast for a multi-horizon play: https://app.k3vl4r.com/r/adma-ai-stock-forecast-8be4093a1cfd1a21b3dcf2efaa54cd00?utm_source=x&utm_medium=social&utm_campaign=report_drop&utm_content=ADMA #stocks #StockMarket
1 · Reply
Princeredyr
Princeredyr Jul. 1 at 3:39 PM
$ADMA got a bunch at 10 before the ER drop. Don’t intend to sell until we’re fairly price . Adam needs to right the ship .
1 · Reply
BullMaven
BullMaven Jul. 1 at 3:15 PM
$ADMA will no sell a single share below 20+
0 · Reply